GlaxoSmithKline plans to split into two businesses – one for Rx drugs and vaccines, and the other for OTC products – after forming a new joint venture with Pfizer’s consumer health division.
Ad-ventures in Marketing XI
Artificial Intelligence, Business, Data Security, December 2018, Digiceuticals, Doctors, Gastroesophageal Reflux Disease (GERD), Healthcare Communications Agencies, Healthcare Physicians, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome, Issue Archives, Joint Ventures, Marketing & Advertising, Partnerships, Patient Identification, Patients, Pharma, Pharmaceutical Marketing Ventures to Watch, Pharmacy Benefits, Rare Diseases, Rare Disorders, Sales Aids, Siri, Special Features, Start-Ups, TherapistsFor the 11th year, Med Ad News selected new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
Google’s Verily will team up with ResMed, a company that specializes in treating sleep disorders, to launch a joint business venture to address sleep apnea and other sleeping disorders.
Ahead of Takeda Pharmaceutical’s acquisition of Dublin-based Shire, the Japan-based company is divesting its majority stake in a Chinese joint venture for about $280 million.
Corning announced at President Trump’s “Made in America” event that the company planned to create 1,000 new high-tech jobs in the U.S.
Nestle is investing 20 million euros in a joint venture with Enterome SA to develop microbiome-based diagnostics for inflammatory bowel and liver diseases.
Intouch Solutions and Healthware International signed a definitive agreement to share ownership of a new joint venture that will serve the needs of life science clients worldwide.
French drugmaker Sanofi and Google owner Alphabet’s life sciences firm Verily are to invest about $500 million in a diabetes joint venture combining devices with services, an example of growing ties between the pharma and tech sectors.
Casebia Therapeutics, a joint venture between Bayer and CRISPR Therapeutics, plans to open laboratory and office space in Cambridge, Mass.
Top 20 Life Science Startups to Watch in the U.S.
Alzheimer's, Alzheimer's Diseases, Angelman Syndrome, Biopharma, Biotech, Biotechnology, Business, Checkpoint Inhibitors, Clinical Trials, Collaboration, Collaborations, Collaborations, Deals, DNA, Financing, Fragile X Syndrome, Genomics, HIV, HIV/AIDS, Immuno-oncology, Joint Ventures, Joint Ventures, Licensing, Life Sciences, Nasal Sprays, Niemann-Pick C Disease (NPC), Personalized Medicine, R&D, Royalties, Spin-outs, Start-ups, Startups, T-CellsBioSpace (DHX) is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the […]